China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 215 full-time employees. The company went IPO on 2000-02-15. The firm is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The firm's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The firm's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The firm mainly operates in the domestic market.
Quels sont les états financiers clés de China Pharma Holdings Inc ?
Selon le dernier état financier (Form-10K), China Pharma Holdings Inc a un total d'actifs de $0, un bénéfice net 손실 de $0
Quels sont les ratios financiers clés pour CPHI ?
Le ratio de liquidité de China Pharma Holdings Inc est 0, la marge nette est 0, les ventes par action sont de $0.
Comment les revenus de China Pharma Holdings Inc sont-ils répartis par segment ou géographie ?
China Pharma Holdings Inc 주요 수익원은 Pharmaceutical Products이며, 최신 수익 발표에서 수익은 4,144,268입니다. 지역별로는 China이 China Pharma Holdings Inc의 주요 시장이며, 수익은 4,144,268입니다.
China Pharma Holdings Inc est-elle rentable ?
no, selon les derniers états financiers, China Pharma Holdings Inc a un bénéfice net 손실 de $0
China Pharma Holdings Inc a-t-elle des passifs ?
no, China Pharma Holdings Inc a un passif de 0
Combien d'actions en circulation China Pharma Holdings Inc a-t-elle ?
China Pharma Holdings Inc a un total d'actions en circulation de 0